MedPath

Treatment of Hyperpyrexia and in the Pediatric Emergency Department (FEVER_ED)

Active, not recruiting
Conditions
Fever
Registration Number
NCT06194383
Lead Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brief Summary

Fever represents the main cause of admission to the emergency room in older people pediatric. It occurs in the presence of a wide range of pathologies, from infectious forms (the most common, viral or bacterial) up to more complex and/or systemic forms (such as inflammatory or neoplastic ones). The drugs currently indicated for the management of fever in children are: paracetamol and ibuprofen. There are no recent studies conducted in pediatric population, who have demonstrated the greater effectiveness of therapy with paracetamol or ibuprofen, The objective of our study is, therefore, to identify which therapy is most appropriate for controlling body temperature e of associated symptoms in pediatric patients arriving in the emergency room with fever.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
160
Inclusion Criteria
  • Pediatric patients (aged between 6 months 0 and 20 years)
  • fever (T > 38°C) with/without associated symptoms, treated with standard antipyretic drugs orally (paracetamol, ibuprofen or paracetamol/ibuprofen combination)
  • who have expressed their consent to participate in the study.
Exclusion Criteria
  • age <6 months or >20 years;
  • patients who did not express consent to participate in the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response to the treatment as evaluation of associated symptoms1 hour

Evaluation of associated symptoms by pain scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Fondazione Policlinico Universitario A. Gemelli IRCCS

🇮🇹

Roma, Italy

© Copyright 2025. All Rights Reserved by MedPath